Filing Details

Accession Number:
0001127602-24-016776
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-29 16:16:35
Reporting Period:
2024-05-24
Accepted Time:
2024-05-29 16:16:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882796 Biocryst Pharmaceuticals Inc BCRX Biological Products, (No Disgnostic Substances) (2836) 621413174
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1221599 Steve Aselage 4505 Emperor Boulevard
Suite 200
Durham NC 27703
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-05-24 2,500 $6.40 2,500 No 4 P Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 63,339 Direct